All Title Author
Keywords Abstract

l-2-Oxothiazolidine-4-Carboxylic Acid or α-Lipoic Acid Attenuates Airway Remodeling: Involvement of Nuclear Factor-κB (NF-κB), Nuclear Factor Erythroid 2p45-Related Factor-2 (Nrf2), and Hypoxia-Inducible Factor (HIF)

DOI: 10.3390/ijms13077915

Keywords: airway remodeling, antioxidant, hypoxia-inducible factor, nuclear factor erythroid 2p45-related factor-2, nuclear factor-κB, oxidative stress

Full-Text   Cite this paper   Add to My Lib


Reactive oxygen species (ROS) play a crucial role in the pathogenesis of acute and chronic respiratory diseases. Antioxidants have been found to ameliorate airway inflammation and hyperresponsiveness in animal models employing short-term exposure to allergen. However, little data are available on the effect of antioxidants on airway remodeling and signaling pathways in chronic asthma. In the present study, we used a long-term exposure murine model of allergic airway disease to evaluate the effects of an antioxidant, l-2-oxothiazolidine-4-carboxylic acid (OTC) or α-lipoic acid (LA) on airway remodeling, focusing on the ROS-related hypoxia-inducible signaling. Long-term challenge of ovalbumin (OVA) increased ROS production, airway inflammation, and airway hyperresponsiveness, and developed features of airway remodeling such as excessive mucus secretion, subepithelial fibrosis, and thickening of the peribronchial smooth muscle layer. Administration of OTC or LA reduced these features of asthma, including airway remodeling, which was accompanied by suppression of transforming growth factor-β1, vascular endothelial growth factor, and T-helper 2 cytokines. In addition, OVA-induced activation of nuclear factor-κB (NF-κB), nuclear factor erythroid 2p45-related factor-2 (Nrf2), hypoxia-inducible factor (HIF)-1α, and HIF-2α was reduced by OTC or LA. Our results also showed that OTC or LA down-regulated phosphoinositide 3-kinase activity and decreased phosphorylation of p38 mitogen-activated protein kinase but not extracellular signal-regulated kinase 1/2 or c-Jun N-terminal kinase. These findings demonstrate that OTC and LA can inhibit activation of NF-κB, Nrf2, and HIF, leading to attenuate allergen-induced airway remodeling.


[1]  Chiappara, G.; Gagliardo, R.; Siena, A.; Bonsignore, M.R.; Bousquet, J.; Bonsignore, G.; Vignola, A.M. Airway remodelling in the pathogenesis of asthma. Curr. Opin. Allergy Clin. Immunol 2001, 1, 85–93.
[2]  Park, S.J.; Lee, Y.C. Antioxidants as novel agents for asthma. Mini Rev. Med. Chem 2006, 6, 235–240.
[3]  De Boer, W.I.; Yao, H.; Rahman, I. Future therapeutic treatment of COPD: Struggle between oxidants and cytokines. Int. J. Chron. Obstruct. Pulmon. Dis 2007, 2, 205–228.
[4]  Comhair, S.A.; Erzurum, S.C. Redox control of asthma: Molecular mechanisms and therapeutic opportunities. Antioxid. Redox Signal 2010, 12, 93–124.
[5]  Lee, Y.C.; Lee, K.S.; Park, S.J.; Park, H.S.; Lim, J.S.; Park, K.H.; Im, M.J.; Choi, I.W.; Lee, H.K.; Kim, U.H. Blockade of airway hyperresponsiveness and inflammation in a murine model of asthma by a prodrug of cysteine, L-2-oxothiazolidine-4-carboxylic acid. FASEB J 2004, 18, 1917–1919.
[6]  Tanabe, T.; Fujimoto, K.; Yasuo, M.; Tsushima, K.; Yoshida, K.; Ise, H.; Yamaya, M. Modulation of mucus production by interleukin-13 receptor alpha2 in the human airway epithelium. Clin. Exp. Allergy 2008, 38, 122–134.
[7]  Yasuo, M.; Fujimoto, K.; Tanabe, T.; Yaegashi, H.; Tsushima, K.; Takasuna, K.; Koike, T.; Yamaya, M.; Nikaido, T. Relationship between calcium-activated chloride channel 1 and MUC5AC in goblet cell hyperplasia induced by interleukin-13 in human bronchial epithelial cells. Respiration 2006, 73, 347–359.
[8]  Cheng, S.E.; Lee, I.T.; Lin, C.C.; Kou, Y.R.; Yang, C.M. Cigarette smoke particle-phase extract induces HO-1 expression in human tracheal smooth muscle cells: Role of the c-Src/NADPH oxidase/MAPK/Nrf2 signaling pathway. Free Radic. Biol. Med 2010, 48, 1410–1422.
[9]  Papaiahgari, S.; Zhang, Q.; Kleeberger, S.R.; Cho, H.Y.; Reddy, S.P. Hyperoxia stimulates an Nrf2-ARE transcriptional response via ROS-EGFR-PI3K-Akt/ERK MAP kinase signaling in pulmonary epithelial cells. Antioxid. Redox Signal 2006, 8, 43–52.
[10]  Koshikawa, N.; Hayashi, J.; Nakagawara, A.; Takenaga, K. Reactive oxygen species-generating mitochondrial DNA mutation up-regulates hypoxia-inducible factor-1alpha gene transcription via phosphatidylinositol 3-kinase-Akt/protein kinase C/histone deacetylase pathway. J. Biol. Chem 2009, 284, 33185–33194.
[11]  Polosukhin, V.V.; Cates, J.M.; Lawson, W.E.; Milstone, A.P.; Matafonov, A.G.; Massion, P.P.; Lee, J.W.; Randell, S.H.; Blackwell, T.S. Hypoxia-inducible factor-1 signalling promotes goblet cell hyperplasia in airway epithelium. J. Pathol 2011, 224, 203–211.
[12]  Jiang, H.; Zhu, Y.S.; Xu, H.; Sun, Y.; Li, Q.F. Inflammatory stimulation and hypoxia cooperatively activate HIF-1α in bronchial epithelial cells: Involvement of PI3K and NF-κB. Am. J. Physiol. Lung Cell. Mol. Physiol 2010, 298, L660–L669.
[13]  Vita, J.A.; Frei, B.; Holbrook, M.; Gokce, N.; Leaf, C.; Keaney, J.F. L-2-Oxothiazolidine-4-carboxylic acid reverses endothelial dysfunction in patients with coronary artery disease. J. Clin. Invest 1998, 101, 1408–1414.
[14]  Packer, L.; Witt, E.H.; Tritschler, H.J. Alpha-lipoic acid as a biological antioxidant. Free Radic. Biol. Med 1995, 19, 227–250.
[15]  Lee, K.S.; Kim, S.R.; Park, S.J.; Min, K.H.; Lee, K.Y.; Jin, S.M.; Yoo, W.H.; Lee, Y.C. Antioxidant down-regulates IL-18 expression in asthma. Mol. Pharmacol 2006, 70, 1184–1193.
[16]  Fattouh, R.; Jordana, M. TGF-beta, eosinophils and IL-13 in allergic airway remodeling: A critical appraisal with therapeutic considerations. Inflamm. Allergy Drug Targets 2008, 7, 224–236.
[17]  Siddiqui, S.; Sutcliffe, A.; Shikotra, A.; Woodman, L.; Doe, C.; McKenna, S.; Wardlaw, A.; Bradding, P.; Pavord, I.; Brightling, C. Vascular remodeling is a feature of asthma and nonasthmatic eosinophilic bronchitis. J. Allergy Clin. Immunol 2007, 120, 813–819.
[18]  Doherty, T.; Broide, D. Cytokines and growth factors in airway remodeling in asthma. Curr. Opin. Immunol 2007, 19, 676–680.
[19]  Huerta-Yepez, S.; Baay-Guzman, G.J.; Garcia-Zepeda, R.; Hernandez-Pando, R.; Vega, M.I.; Gonzalez-Bonilla, C.; Bonavida, B. 2-Methoxyestradiol (2-ME) reduces the airway inflammation and remodeling in an experimental mouse model. Clin. Immunol 2008, 129, 313–324.
[20]  Liang, K.C.; Lee, C.W.; Lin, W.N.; Lin, C.C.; Wu, C.B.; Luo, S.F.; Yang, C.M. Interleukin-1beta induces MMP-9 expression via p42/p44 MAPK, p38 MAPK, JNK, and nuclear factor-kappaB signaling pathways in human tracheal smooth muscle cells. J. Cell. Physiol 2007, 211, 759–770.
[21]  Hulsmann, A.R.; Raatgeep, H.R.; den Hollander, J.C.; Stijnen, T.; Saxena, P.R.; Kerrebijn, K.F.; de Jongste, J.C. Oxidative epithelial damage produces hyperresponsiveness of human peripheral airways. Am. J. Respir. Crit. Care Med 1994, 149, 519–525.
[22]  Chaudiere, J.; Ferrari-Iliou, R. Intracellular antioxidants from chemical to biochemical mechanisms. Food Chem. Toxicol 1999, 37, 949–962.
[23]  Heffner, J.A.; Repine, J.E. State of the art: Pulmonary strategies of antioxidant defense. Am. Rev. Respir. Dis 1989, 140, 531–554.
[24]  Toth, K.M.; Clifford, D.P.; Berger, E.M.; White, C.W.; Repine, J.E. Intact human erythrocyte prevent hydrogen peroxide mediated damage to isolated perfused rat lungs and cultured bovine pulmonary artery endothelial cells. J. Clin. Invest 1984, 74, 292–295.
[25]  Van Asbeck, B.S.; Hoidal, J.; Vercelloti, G.M.; Schwartz, B.A.; Moldow, C.F.; Jacob, H.S. Protection against lethal hyperoxia by tracheal insufflation of erythrocytes: Role of red cell glutathione. Science 1985, 227, 756–759.
[26]  Comhair, S.A.; Xu, W.; Ghosh, S.; Thunnissen, F.B.; Almasan, A.; Calhoun, W.J.; Janocha, A.J.; Zheng, L.; Hazen, S.L.; Erzurum, S.C. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am. J. Pathol 2005, 166, 663–674.
[27]  Imaoka, H.; Hoshino, T.; Okamoto, M.; Sakazaki, Y.; Sawada, M.; Takei, S.; Kinoshita, T.; Kawayama, T.; Kato, S.; Aizawa, H. Endogenous and exogenous thioredoxin 1 prevents goblet cell hyperplasia in a chronic antigen exposure asthma model. Allergol. Int 2009, 58, 403–410.
[28]  Voynow, J.A.; Fischer, B.M.; Malarkey, D.E.; Burch, L.H.; Wong, T.; Longphre, M.; Ho, S.B.; Foster, W.M. Neutrophil elastase induces mucus cell metaplasia in mouse lung. Am. J. Physiol. Lung Cell. Mol. Physiol 2004, 287, L1293–L1302.
[29]  De Marco, V.G.; Habibi, J.; Whaley-Connell, A.T.; Schneider, R.I.; Sowers, J.R.; Andresen, B.T.; Gutweiler, A.A.; Ma, L.; Johnson, M.S.; Ferrario, C.M.; et al. Rosuvastatin ameliorates the development of pulmonary arterial hypertension in the transgenic (mRen2)27 rat. Am. J. Physiol. Heart Circ. Physiol 2009, 297, H1128–H1139.
[30]  Koli, K.; Myll?rniemi, M.; Keski-Oja, J.; Kinnula, V.L. Transforming growth factor-beta activation in the lung: Focus on fibrosis and reactive oxygen species. Antioxid. Redox Signal 2008, 10, 333–342.
[31]  Cho, J.Y.; Miller, M.; Baek, K.J.; Han, J.W.; Nayar, J.; Lee, S.Y.; McElwain, K.; McElwain, S.; Friedman, S.; Broide, D.H. Inhibition of airway remodeling in IL-5-deficient mice. J. Clin. Invest 2004, 113, 551–560.
[32]  Lee, K.S.; Park, S.J.; Kim, S.R.; Min, K.H.; Lee, K.Y.; Choe, Y.H.; Hong, S.H.; Lee, Y.R.; Kim, J.S.; Hong, S.J.; Lee, Y.C. Inhibition of VEGF blocks TGF-beta1 production through a PI3K/Akt signalling pathway. Eur. Respir. J 2008, 31, 523–531.
[33]  Cho, H.Y.; Kleeberger, S.R. Nrf2 protects against airway disorders. Toxicol. Appl. Pharmacol 2010, 244, 43–56.
[34]  Semenza, G.L. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu. Rev. Cell Dev. Biol 1999, 15, 551–578.
[35]  Wiesener, M.S.; Jürgensen, J.S.; Rosenberger, C.; Scholze, C.K.; H?rstrup, J.H.; Warnecke, C.; Mandriota, S.; Bechmann, I.; Frei, U.A.; Pugh, C.W.; et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB J 2003, 17, 271–273.
[36]  Lambert, C.M.; Roy, M.; Robitaille, G.A.; Richard, D.E.; Bonnet, S. HIF-1 inhibition decreases systemic vascular remodelling diseases by promoting apoptosis through a hexokinase 2-dependent mechanism. Cardiovasc. Res 2010, 88, 196–204.
[37]  Patten, D.A.; Lafleur, V.N.; Robitaille, G.A.; Chan, D.A.; Giaccia, A.J.; Richard, D.E. Hypoxia-inducible factor-1 activation in nonhypoxic conditions: The essential role of mitochondrial-derived reactive oxygen species. Mol. Biol. Cell 2010, 21, 3247–3257.
[38]  Liu, J.; Yoshida, Y.; Yamashita, U. DNA-binding activity of NF-kappaB and phosphorylation of p65 are induced by N-acetylcysteine through phosphatidylinositol (PI) 3-kinase. Mol. Immunol 2008, 45, 3984–3989.
[39]  Park, S.J.; Lee, K.S.; Kim, S.R.; Min, K.H.; Moon, H.; Lee, M.H.; Chung, C.R.; Han, H.J.; Puri, K.D.; Lee, Y.C. Phosphoinositide 3-kinase δ inhibitor suppresses IL-17 expression in a murine asthma model. Eur. Respir. J 2010, 36, 1448–1459.
[40]  Boutten, A.; Goven, D.; Boczkowski, J.; Bonay, M. Oxidative stress targets in pulmonary emphysema: Focus on the Nrf2 pathway. Expert Opin. Ther. Targets 2010, 14, 329–346.
[41]  Minet, E.; Arnould, T.; Michel, G.; Roland, I.; Mottet, D.; Raes, M.; Remacle, J.; Michiels, C. ERK activation upon hypoxia: Involvement in HIF-1 activation. FEBS Lett 2000, 468, 53–58.
[42]  Sang, N.; Stiehl, D.P.; Bohensky, J.; Leshchinsky, I.; Srinivas, V.; Caro, J. MAPK signaling upregulates the activity of hypoxia-inducible factors by its effects on p300. J. Biol. Chem 2003, 278, 14013–14019.
[43]  Richard, D.E.; Berra, E.; Gothie, E.; Roux, D.; Pouysségur, J. p42/p44 mitogen-activated protein kinases phosphorylate hypoxia-inducible factor 1α (HIF-1α) and enhance the transcriptional activity of HIF-1. J. Biol. Chem 1999, 274, 32631–32637.
[44]  Lu, Y.; Azad, N.; Wang, L.; Iyer, A.K.; Castranova, V.; Jiang, B.H.; Rojanasakul, Y. Phosphatidylinositol-3-kinase/akt regulates bleomycin-induced fibroblast proliferation and collagen production. Am. J. Respir. Cell Mol. Biol 2010, 42, 432–441.
[45]  Lee, K.S.; Kim, S.R.; Park, S.J.; Min, K.H.; Lee, K.Y.; Choe, Y.H.; Park, S.Y.; Chai, O.H.; Zhang, X.; Song, C.H.; Lee, Y.C. Mast cells can mediate vascular permeability through regulation of the PI3K-HIF-1alpha-VEGF axis. Am. J. Respir. Crit. Care Med 2008, 178, 787–797.
[46]  Institute of Laboratory Animal Research. Guide for the Care and Use of Laboratory Animals; National Acamedy Press: Washington, DC, USA, 1996.
[47]  Kwak, Y.G.; Song, C.H.; Yi, H.K.; Hwang, P.H.; Kim, J.S.; Lee, K.S.; Lee, Y.C. Involvement of PTEN in airway hyperresponsiveness and inflammation in bronchial asthma. J. Clin. Invest 2003, 111, 1083–1092.
[48]  Royce, S.G.; Wainewright, J.S.; Samuel, C.S.; Tang, M.L. Comparison of airway remodeling in acute, subacute, and chronic models of allergic airways disease. Am. J. Respir. Cell Mol. Biol 2007, 36, 625–632.
[49]  Lee, K.S.; Kim, S.R.; Park, S.J.; Park, H.S.; Min, K.H.; Jin, S.M.; Lee, M.K.; Kim, U.H.; Lee, Y.C. Peroxisome proliferator activated receptor-gamma modulates reactive oxygen species generation and activation of nuclear factor-kappaB and hypoxia-inducible factor 1alpha in allergic airway disease of mice. J. Allergy Clin. Immunol 2006, 118, 120–127.
[50]  Lee, K.S.; Park, S.J.; Kim, S.R.; Min, K.H.; Jin, S.M.; Lee, H.K.; Lee, Y.C. Modulation of airway remodeling and airway inflammation by peroxisome proliferator-activated receptor gamma in a murine model of toluene diisocyanate-induced asthma. J. Immunol 2006, 177, 5248–5257.


comments powered by Disqus